Pancreatic Cell News Volume 15.26 | Nov 5 2024

    0
    21







    2024-11-05 | PACN 15.26


    Pancreatic Cell News by STEMCELL Technologies
    Vol. 15.26 – 5 November, 2024
    TOP STORY

    Transplantation of Chemically Induced Pluripotent Stem-Cell-Derived Islets under Abdominal Anterior Rectus Sheath in a Type 1 Diabetes Patient

    Investigators reported for the first time autologous transplantation of chemically induced pluripotent stem cell-derived islets into a patient with type 1 diabetes with immunosuppression as part of an exploratory clinical study.
    [Cell]

    Full ArticleGraphical Abstract
    November 2024 Science Events
    PUBLICATIONSListed by the impact factor of the journal

    Heterogeneous Enhancer States Orchestrate β Cell Responses to Metabolic Stress

    The authors profiled single-nuclei RNA along with enhancer marks H3K4me1 or H3K27ac in islets from lean or obese mice. They identified distinct gene signatures and enhancer states correlating with β cell dysfunction trajectory.
    [Nature Communications]

    Full Article

    Double Transgenic Neonatal Porcine Islets as an Alternative Source for Beta Cell Replacement Therapy

    Investigators described in vitro characterization of the secretory function of pancreatic islets, derived from transgenic pigs expressing the glucagon-like-peptide-1-1M3R cassette under the porcine insulin promoter, and their usage to treat insulin-dependent diabetes in an immunodeficient mouse model.
    [Proceedings of The National Academy of Sciences of The United States of America]

    Abstract

    Effect of Fenofibrate on Residual Beta Cell Function in Adults and Adolescents with Newly Diagnosed Type 1 Diabetes: A Randomized Clinical Trial

    The aim of this Phase II, placebo-controlled, double-blinded, randomized clinical trial was to investigate the efficacy and safety of fenofibrate in adults and adolescents with newly diagnosed type 1 diabetes.
    [Diabetologia]

    Full ArticleGraphical Abstract

    Targeting a Chemo-Induced Adaptive Signaling Circuit Confers Therapeutic Vulnerabilities in Pancreatic Cancer

    Investigators reported a previously unknown chemo-induced symbiotic signaling circuit that adaptively conferred chemoresistance in patients and mice with advanced PDAC.
    [Cell Discovery]

    Full Article

    Fibrolytic Vaccination against ADAM12 Reduces Desmoplasia in Preclinical Pancreatic Adenocarcinomas

    Researchers tested prophylactic and therapeutic vaccination against ADAM12 in murine pancreatic ductal adenocarcinoma and observed delayed tumor growth along with a reduction in cancer-associated fibroblasts and tumor desmoplasia.
    [EMBO Molecular Medicine]

    Full Article

    CCL3 Predicts Exceptional Response to TGFβ Inhibition in Basal-Like Pancreatic Cancer Enriched in LIF-Producing Macrophages

    Baseline plasma levels of chemokine chemokine ligand 3 (CCL3) were integrated with clinical outcomes in PDAC patients treated with galunisertib plus gemcitabine or placebo plus gemcitabine.
    [NPJ Precision Oncology]

    Full Article

    KRAS-Mediated Upregulation of CIP2A Promotes Suppression of PP2A-B56α to Initiate Pancreatic Cancer Development

    Scientists demonstrated that KRASG12D induced the expression of an endogenous inhibitor of protein phosphatase 2A (PP2A) activity, cancerous inhibitor of PP2A (CIP2A), and phosphorylation of the PP2A substrate, c-MYC.
    [Oncogene]

    Abstract

    SEMA7A-Mediated Juxtacrine Stimulation of IGFBP-3 Upregulates IL-17RB at Pancreatic Cancer Invasive Front

    Investigators unveiled a multistep process for interleukin 17 receptor B (IL-17RB) upregulation at the invasive margin, which occured through direct communication between tumor cells and fibroblasts.
    [Cancer Gene Therapy]

    Full Article

    Recombinant Newcastle Disease Virus Harboring PTEN Suppresses Pancreatic Ductal Adenocarcinoma Growth by Inhibiting PI3K/AKT/mTOR Signaling and Promoting Apoptosis

    Researchers created a recombinant Newcastle disease virus containing the PTEN gene to investigate its PDAC cell-killing and tumor-suppression effects in PDAC cells transplanted into mice.
    [Molecular Therapy Oncology]

    AbstractGraphical Abstract

    Tumor Organoids Improve Mutation Detection of Pancreatic Ductal Adenocarcinoma

    Scientists investigated the utility of patient-derived organoids (PDOs) to overcome the obstacles of detecting somatic mutations and enhance somatic mutation identification. Surgically resected PDAC tumors and their paired PDOs from 21 patients were examined.
    [Scientific Reports]

    Full Article
    Connect with us via LiveChat to ask your scientific support questions
    REVIEWS

    The Epidemiology of Type 1 Diabetes Mellitus in Older Adults

    The authors summarize the evidence regarding the epidemiology of type 1 diabetes mellitus in older adults as well as the genetics, immunology, and diagnostic challenges.
    [Nature Reviews Endocrinology]

    Full Article
    INDUSTRY AND POLICY NEWS

    Rogel Cancer Center Receives $50M Gift to Revolutionize Pancreatic Cancer Care, Research

    With a $50 million gift from Richard and Susan Rogel, the University of Michigan Health Rogel Cancer Center aims to revolutionize how the world detects, treats, and ultimately cures pancreatic cancer.
    [Michigan Medicine]

    Press Release

    How Studying Ticks Is Helping Treat Diabetes

    The University of Oxford has been given a share of £2 million to study whether saliva from parasitic ticks could remove the need for immunosuppressant drugs when treating type 1 diabetes.
    [BBC]

    Press Release
    FEATURED EVENT

    Organoid Symposium

    December 2-3, 2024
    Toronto, Ontario, Canada & Online

    > See All Events

    JOB OPPORTUNITIES

    Assistant Professor – Molecular Genetics & Microbiology

    University of New Mexico – Albuquerque, New Mexico, United States

    Postdoctoral Fellow – Precision Oncology of Gastrointestinal Cancers

    City of Hope – Monrovia, California, United States

    Associate Professor – Cancer Biology

    University of Pennsylvania – Philadelphia, Pennsylvania, United States

    Postdoctoral Research Fellow – Pancreatic Cancer Metabolism

    University of Oklahoma Health Sciences Center – Oklahoma City, Oklahoma, United States

    Postdoctoral Research Fellow – Pancreatic Cancer Biology

    Dana-Farber Cancer Institute – Boston, Massachusetts, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2